Rhaponticum repens
Rhaponticum repens · Accepted scientific name
Scientific literature: Very Sparse (3 studies) · ★☆☆☆☆
Rhaponticum repens is a botanical species recognized for its significant therapeutic potential in pharmacological research. Various preparations, including methanolic, chloroformic, and ethanol extracts as well as nanoemulsions of essential oils, have been utilized to study its bioactive properties. These preparations contain key phytochemicals such as 4'-Hydroxywogonin, Apigenin 7-O-beta-D-glucoside, Cynaropicrin, and Daucosterol. Scientific investigations have demonstrated that the plant possesses potent antimicrobial, antioxidant, and antiparasitic activities. Specifically, its efficacy has been tested against diverse biological threats, including E. coli, Leishmania major, and Plasmodium falciparum.
- Synonyms
- Centaurea Picris · Carduus Picris · 17 more
- Common names
- Not available
- Family
- Asteraceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Rhaponticum repens is a plant known by a diverse array of regional and linguistic names. In certain areas, it is commonly referred to as Arokaunokki or Ch'ildích'l'iłibáhí. Those speaking German may recognize it as Federblume, while English speakers often call it Hardheads. Additionally, the name Karčioji šerpeta is used to identify this species in other cultural contexts. These varied monikers highlight the plant's wide geographical distribution and its presence in many different traditions.
Sources: Catalogue of Life (COL)
Synonyms
Rhaponticum repens is a botanical subject frequently encountered under various scientific names due to its complex taxonomic history. It is widely recognized by the synonym Acroptilon angustifolium, which highlights specific morphological variations. Furthermore, the plant is often categorized as Acroptilon australe or Acroptilon obtusifolium in different botanical records. Researchers also frequently refer to it as Acroptilon picris to describe its characteristics. Finally, certain specialized studies identify this species as Acroptilon picris var. angustifolium to denote its distinct varieties.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Rhaponticum repens is a distinctive member of the kingdom Plantae. Within this vast botanical realm, the species is classified under the class Equisetopsida. It belongs to the order Asterales, showcasing its specific evolutionary lineage. Further specialization is found in its placement within the family Asteraceae. Ultimately, this plant is identified by its unique designation under the genus Rhaponticum.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asterales |
| Family | Asteraceae |
| Genus | Rhaponticum |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Rhaponticum repens exhibits a broad geographical range that spans across both the African and Asian continents. In Africa, this species is widely distributed throughout Southern Africa, specifically within the Cape Provinces, the Free State, and the Northern Provinces. Its reach extends significantly into the Asia-Temperate region as well. Within this territory, the plant can be found inhabiting the Caucasus and the Transcaucasus regions. This diverse distribution highlights the plant's ability to adapt to various environmental conditions across different hemispheres.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Rhaponticum repens has emerged as a significant subject of pharmacological interest due to its diverse range of biological activities. Research indicates that the plant possesses notable antimicrobial properties, making its extracts potential candidates for combating infectious diseases. Furthermore, studies have demonstrated its antioxidant potential through various screening methods, including the DPPH test. Beyond these effects, the plant also exhibits significant in vitro antiparasitic activity, particularly showing inhibition against Leishmania major. These multifaceted therapeutic qualities highlight the potential of Rhaponticum repens as a valuable source for natural drug discovery.
Compounds
Rhaponticum repens, also identified in scientific literature as Acroptilon repens, possesses a complex chemical profile revealed through ethanol extraction and chromatographic purification. Detailed spectral analysis has confirmed that this plant contains several significant bioactive compounds. Specifically, the species is found to contain 4'-Hydroxywogonin and Apigenin 7-O-beta-D-glucoside. Furthermore, the chemical composition includes the presence of Cynaropicrin and Daucosterol. The study also identifies Ethyl caffeate as one of the key constituents isolated from this plant.
Conditions
Rhaponticum repens exhibits significant biological activity against a variety of harmful organisms. The essential oil of this plant has demonstrated the ability to treat Anopheles stephensi larvae. Furthermore, its extracts possess antimicrobial properties that effectively treat the bacteria B. subtilis and E. coli. The plant also shows efficacy in treating fungal pathogens, specifically Botrytis cinerea and Fusarium oxysporum. These diverse relationships highlight the plant's potential as a natural agent against various pests and microbes.
Preparations
Rhaponticum repens is prepared as methanolic extracts to evaluate its in vitro antiparasitic activity against Plasmodium falciparum and Leishmania major. This plant is also processed as chloroformic extracts to study its antimicrobial and antioxidant properties against various bacteria and fungi. Researchers have utilized the ethanol extract of the plant to isolate and identify specific chemical constituents through chromatography. Furthermore, the hydroalcoholic extract of Rhaponticum repens has been used in toxicological studies to assess its effects on oxidative stress and mitochondrial function in mice. Finally, the plant's essential oil can be formulated as a nanoemulsion, although studies indicate such a preparation may show weak efficacy as a larvicide.